- Country: Chile
- Summary: Axitinib Supply Agreement for Puerto Montt Hospital
- CLT Ref No: 130671361
- Deadline: 15 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 1058128-27-LP25
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Products or services: Rituximab
The Puerto Montt Hospital requires to hire a supplier capable of executing an agreement to supply AXITINIB, necessary for the curative treatment of hematocology patients with pathologies such as chronic myeloid leukemia, multiple myeloma and thyroid cancer, among others, in adults and children, in accordance with Exempt Resolution NO12,499, issued on October 29, 2024, which approves the Therapeutic Arsenal of the Puerto Hospital Montt. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAxitinib Supply Agreement for Puerto Montt Hospital - Chile Tender
The PUERTO MONTT HOSPITAL RELONCAVI HEALTH SERVICE, a Government sector organization in Chile, has announced a new tender for Axitinib Supply Agreement for Puerto Montt Hospital. This tender is published on ChileTenders under CLT Ref No: 130671361 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-15.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
